Dar M S
Department of Pharmacology, School of Medicine, East Carolina University, Greenville, North Carolina.
J Pharmacol Exp Ther. 1990 Dec;255(3):1202-9.
To clarify if the behavioral interaction between ethanol and adenosine reported previously occur centrally or due to a peripheral hemodynamic change, the effect of i.c.v. adenosine agonists, N6-(R-phenylisopropyl)adenosine (R-PIA), N6-(S-phenylisopropyl)adenosine, 5'-(N-cyclopropyl)-carboxamidoadenosine, antagonists, theophylline and 8-p-(sulfophenyl)theophylline as well as enprofylline on ethanol-(i.p.)-induced motor incoordination was evaluated by rotorod. Adenosine agonists and antagonists dose dependently accentuated and attenuated, respectively, ethanol-induced motor incoordination, thereby suggesting a central mechanism of adenosine modulation of this effect of ethanol and confirmed our previous reports in which adenosine agonists and antagonists were given i.p. Enprofylline, a weak adenosine antagonist but potent inhibitor of cyclic AMP phosphodiesterase, did not alter ethanol's motor incoordination, further supporting involvement of brain adenosine receptor mechanism(s) in ethanol-adenosine interactions. Results from R-PIA and N6-(S-phenylisopropyl)adenosine experiments showed nearly a 40-fold greater potency of R-vs. S-diastereoisomer, suggesting predominance of adenosine A1 subtype. However, 5'-(N-cyclopropyl)-carboxamidoadenosine data indicate complexity of the mechanism(s) and point toward an additional involvement of a yet unknown subtype of adenosine A2. No effect of ethanol on blood or brain levels of [3H]R-PIA was noted and sufficient amount of the latter entered the brain to suggest adenosine receptor activation adequate to produce behavioral interaction with ethanol. There was no escape of i.c.v.-administered [3H]R-PIA from brain to the peripheral circulation ruling out a peripheral and supporting a central mechanism of ethanol-adenosine interaction.(ABSTRACT TRUNCATED AT 250 WORDS)
为了阐明先前报道的乙醇与腺苷之间的行为相互作用是发生在中枢还是由于外周血流动力学变化,通过转棒试验评估了脑室内注射腺苷激动剂N6-(R-苯异丙基)腺苷(R-PIA)、N6-(S-苯异丙基)腺苷、5'-(N-环丙基)-羧酰胺腺苷、拮抗剂茶碱和8-对-(磺基苯基)茶碱以及恩丙茶碱对乙醇腹腔注射诱导的运动不协调的影响。腺苷激动剂和拮抗剂分别剂量依赖性地加重和减轻乙醇诱导的运动不协调,从而提示腺苷对乙醇这种作用的调节存在中枢机制,并证实了我们先前腹腔注射腺苷激动剂和拮抗剂的报道。恩丙茶碱是一种弱腺苷拮抗剂但却是环磷酸腺苷磷酸二酯酶的强效抑制剂,它并未改变乙醇的运动不协调,进一步支持脑腺苷受体机制参与乙醇-腺苷相互作用。R-PIA和N6-(S-苯异丙基)腺苷实验结果显示R-非对映异构体的效力比S-非对映异构体高近40倍,提示腺苷A1亚型占主导。然而,5'-(N-环丙基)-羧酰胺腺苷的数据表明机制复杂,并指出腺苷A2的一种未知亚型可能也参与其中。未观察到乙醇对[3H]R-PIA的血液或脑内水平有影响,且后者有足够量进入脑内提示腺苷受体激活足以产生与乙醇的行为相互作用。脑室内注射的[3H]R-PIA没有从脑内逸出到外周循环,排除了外周机制并支持乙醇-腺苷相互作用的中枢机制。(摘要截短于250字)